THE ROLE OF HEREDITARY DISORDERS OF METABOLISM of FOLIC ACID IN THE DEVELOPMENT OF CONGENITAL DEFECT FETUS IN WOMEN WITH EPILEPSY AND RECEIVING ANTIEPILEPTIC DRUGS
Abstract
About the Authors
D. V. DmitrenkoRussian Federation
N. A. Shnayder
Russian Federation
Y. B. Govorina
Russian Federation
A. V. Muravievа
Russian Federation
K. A. Gazenkampf
Russian Federation
References
1. Dmitrenko D.V. Nevrologiya, neiropsikhiatriya, psikhosomatika. 2014; 1: 31-38. DOI: http://dx.doi.org/10.14412/2074-2711-2014-1S-31-38.
2. Dmitrenko D.V., Shnayder N.A., Egorova A.T. Problemy zhenskogo zdorov’ya. 2012; 2 (7): 63-69.
3. Dmitrenko D.V., Shnayder N.A. Epilepsiya i paroksizmal’nye sostoyaniya. 2014; 6 (2): 60-69.
4. Fetisova I.N., Dobrolyubov A.S., Lipin M.A., Polyakov A.V. Vestnik novykh meditsinskikh tekhnologii. 2007; X (1): 32-38.
5. Coppola G., Ingrosso D., Operto F.F. et al. Role of folic acid depletion on homocysteine serum level in children and adolescents with epilepsy and different MTHFR C677T genotypes. Seizure. 2012; 21 (5): 340-343.
6. Dmitrenko D.V., Shnayder N.A., Kiselev I.A. et al. Problems of rational therapy for epilepsy during pregnancy. Open J. Obstetrics and Gynecology. 2014; 4 (9): 506-515. DOI: http://dx.doi.org/10.4236/ojog.2014.49072.
7. Gueant-Rodriguez R.M., Rendeli C., Namour B. et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci. Lett. 2003; 334 (3): 189-192.
8. Kirke P.N., Mills J.L., Molloy A.M. et.al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case-control study. BMJ. 2004; 328 (7455): 1535-1536.
9. Linnebank M., Moskau S., Semmler A. et al. Antiepileptic drugs interact with folate and vitamin B12 serum levels. Annals of Neurology. 2011; 69 (2): 352-359.
10. Jensen N.O., Olesen O.V. Folic acid and anticonvulsive drugs. Arch Neurol. 1969; 21 (2): 208-214.
11. Pennell P.B. Pregnancy in women who have epilepsy. Neurol.Clin. 2004; 22 (4): 799-820.
12. Shnayder N.A., Pilyugina M.S., Dmitrenko D.V. et al. Pharmacogenetics of valproic acid as unmodified risk factor of adverse drug reactions. MHSJ. 2011; 7: 20-28. DOI: http://dx.doi.org/10.15208/mhsj.2011.129.
Review
For citations:
Dmitrenko D.V., Shnayder N.A., Govorina Y.B., Muravievа A.V., Gazenkampf K.A. THE ROLE OF HEREDITARY DISORDERS OF METABOLISM of FOLIC ACID IN THE DEVELOPMENT OF CONGENITAL DEFECT FETUS IN WOMEN WITH EPILEPSY AND RECEIVING ANTIEPILEPTIC DRUGS. Epilepsy and paroxysmal conditions. 2014;6(4):16-22. (In Russ.)

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.